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Summary
Colorectal cancer is one of the most
common malignancies of the Western
world. The American Cancer Society
estimates that a total of 130,200 new
cases of colorectal cancer wil l be diag-
nosed in the United States o1'America
in the year 2000. Five years survival
rates vary between 90Vo in patients di-
agnosed at an early stage to only 87o in
patients with distal metastases at the
tirne of init ial diagnosis. The overall
f ive years survival rate in persons diag-
nosed with symptomatic colorectal can-
cer is only 5O-607o. Because of the ex-
tent of the disease and the unfavorable
prognosis.  much ef fo l t  is  put  in to in-
creasing our knowledge about the car-
cinogenic process and developing
strategies to prevent colorectal cancer.
This thesis describes the eÍÍècts of
chemo- and dietary interventions aimed
to influence luminal and epithelial fac-
tors associated with colon carcinogene-
sis. Special attention is paid to diÍÍbr-
ent ia l  e l - fects o l '  in tervent ion st rategies
in various parts of the colorectum. In
the second part of this thesis, mecha-
nisms involved in the process of colo-
rectal carcinogenesis are studied, using
the presumably carcinogenic sennoside
laxatives as a model.
The development of colorectal cancer is
a gradual process, involving both ge-
netic and environmental lactors.
Modulating this process by intervening
in environmental factors such as diet
requires the presence of assessable pa-
rameters. The most direct approach,
using colorectal cancer as primary end-
Chapter I I
point, is t ime-consuming and expen-
sive, as it involves the follow-up of
nunrerous pat ients dur ing many years.
Studies with smaller numbers of pa-
tients for a shorter period of time can be
performed if reliable intermediate end-
points of colorectal cancer risk are
available.
One of the fàctors presumably contrib-
uting to colorectal cancer risk is the
composition of the diet. A diet high in
fat increases the concentrations of fatty
acids and secondary bile acids in feces
and fecal water, the aqueous fraction of
lèces.  These substances are cyto lox ic  to
colonic epithelial cells and induce hy-
perproliÍ-eration to restore the colonic
epithelium Íiom the inf'licted damage.
Increased proliferative activity of co-
lonic epithelium is generally considered
one of the primary steps in the process
of colon carcinogenesis. Concentrations
of cytotoxic substances in fèces and the
cytotoxic potential oÍ' Í'ecal water as
well as the proliferative activity of co-
lonic epithelial cells are being used as
intermediate biomarkers of colorectal
cancer risk.
Secondary bile acids, deoxycholic acid
(DCA) and lithocholic acid (LCA) are
Íbrmed in the colon by bacterial 7cr-
dehydroxylation fiom the primary bile
acids cholic acid (CA) and chenode-
oxycholic acid (CDCA) respectively.
The hydrophobic bile acids DCA and
LCA are membrane damaging and
therefore cytotoxic to colonic epithelial
cells.
Ursodeoxycholic acid (UDCA) is a
more hydrophilic bile acid that is nor-
mally only present in the colon in small
amounts. Several protective properties
have been attributed to increased con-
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centrations of UDCA in the colon.
UDCA inhibits membrane-damaging
ef-Íects of hydrophobic bile acids and
reduces the production of CA. which
eventually results in lower concentra-
tions of DCA. We perfornred a ran-
domized placebo-controlled cross-over
study in l5 healthy volunteers to assess
the el'f'ect of 900 m-e/clay of UDCA fbr
four weeks on fecal bile acid con-rposi-
tion ancl cytolytic activity of f 'ecal wa-
ter. Chapter 2 shows that supplemen-
tation with UDCA decreased the per-
centagcs of CA, CDCA and DCA.
whereas the concentrations of these bile
acids in fecal water were nol aÍfected.
Despite high levels of UDCA after
UDCA supplementation. cytolytic ac-
tivity of Íècal water was not reduced.
This could be due to the increased con-
centrations of LCA Ibllowing interven-
tion with UDCA. 'Ihe results of this
study do not support a role l irr UDCA
in the chemoprevention of colorectal
e  i l ncc r  i n  t he  human  s i t ua l i on .
The preferential occurrence of tumors
in the distal colon in regions with a
hi-gh incidencc of colorectal cancer can
probably be ascribed to dietary factors
ancl their ef Íèct on luminal colonic
contents.  Di f f icu l t ies in  obta in ing rep-
resentative san.rples from dif 'f 'erent co-
lonic re'gions have contributed to the
fact  that  l i t t lc  is  actual ly  known about
the composi t ion of  c<l lonic  contents in
the proximal  ancl  d is ta l  co lon.  ln  chap-
ter  3 hemicolectomy pat ients.  in  rvhonr
cither thc proximal (right heniicolec-
tomy) or clistal [ lel ' t hemicolectonry)
colon had been renroved, served as a
rrclclel to evaluate regionai cli l l 'erences
in b i le  ac id nretabci l isnr .  ln  c)  le f t  and l6
i ' ight hernicolectonv patients the per-
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centage of DCA in fèces was lower
than in l7  contro l  subjects wi th an in-
tact colon. Left hemicolectomy patients
had a lower proportion of DCA in cluo-
denal bile than right hen-ricolectomy
patients and those with an intact colon.
This is probably caused by the pre-
dominant absorption of protonated
DCA in the distal colon. Incleed higher
concentrations of protonated DCA were
pressnt in colonic contents of right
hemicolectomy pat ients.  As especia l ly
protonated DCA is thought to be cyto-
t t l x i e  .  i t  i s  no t  su rp r i s i ng  t h l t  ey to (ox i c
activity of f 'ecal water was higher in
right hemicolecton.ry patients. This
study clearly clemonstrates diÍÍerences
in bile acid handling between the
proximal and clistal colon and may help
to understand cliÍÍèrences in cancer risk
between these eolonic  regions.
Right hemicolectomy patients probably
have an increased risk of developin.u
metachronous tumors in the remaining
dista l  co lon.  This might  be due to the
hi-sher cytotoxic activity of fècal water
as shown in chapter  3.  Calc ium and
resistant starch are prornisin-e a-eents Íur
dietary intervention in patients with
increased risk of colorectal cancer. Cal-
cium probably exerts its protective ef-
tbct by binding to secondary bile acids
and other cytotoxic substances. thus
rendering thenr harmless for the colonic
epithcliurn. The protcctive ctÍèct of
resistant starch is probably brought
about by the f 'ermentution oi' resrstant
starch to short chain tatty acids
(SCFA).  Thesc SCFA's can e i ther  exer t
a direct protcctive cfï 'ect on colonic
epitheliurn or indirectly influence the
carcinogenic process by clinrinishin-u
the production rif secondary bile acids
Sum nt a ry, t t tru' I us ir t tt s u rtd 
.fi tl Lt re 1 te r.spe c I iv e s
due to a reduction of fecal pH. Chapter
4 describes the results of two random-
ized placebo-controlled cross-over in-
tervention trials in 2 x 1-5 right hemi-
colectomy pat ients wi th 1.0 g calc ium
and l9 g resistant starch. After two
rnonths of supplementation calcium
reduced fècal water alkaline phospha-
tase activity. a putative marker Íor in-
testinal epitheliolysis, but did not alter
cytotoxicity of fècal water. ProliÍ 'erative
activity in the lurninarl part of colonic
crypts was decreased. A reduction in
l um ina l  p ro l i Í ' e ra t i ve  uc t i v i t y .  even
without atÍècting total prolifèration, is
generally assumed to be beneficial. Re-
sistant starch did not afÍèct either cyto-
toxic activity of fècal water or proliÍ '-
erative activity of colonic epithelial
cells but reduced alkaline phosphatase
activity. This study thus suggests that
only calcium supplementation but not
res is t i rn t  s tarch nr i . ry  h l rve a protect ive
eÍ'fect on colorectal cancer risk in right
hen.ricolectomy patients.
As described in chapter 5. the eÍfects
of calcium and resistant starch were
further evaluated in patients with a
history of benign colorectal adenomas,
who are known to have an increased
rate of epithelial cell proliÍèration and
an enhanced risk of developin-e colo-
rectal carcinoma. After two months of
supplenrentation with either 1.0 g cal-
cium plus piacebo. l9 g resistant starch
plus placebo or two placebos. site spe-
cif ic eÍfects on cell proiitèrative activ-
ity were studied in biopsies of coecum,
transvel'se colon. sigmoicl colon ancl
rectum obtained frorr-r 86 patients with a
history of adenomatous polyps. Pro-
liÍ 'erative activity. erpressed as labeling
index (LI ) .  was s imi lar  in  the three
Cluqtter I )
groups in all areas of the colorectum.
No diÍferences in Ll of dif lerent crypt
compartments or in crvpt length be-
tween the calcium. resistant starch and
placebo group could be observed either.
Caicium and resistant starch do not
seem to af têct  pro l i lèrat ive uct iv i ty .  as
a biomarker Íbr colorectal cancer risk.
in these adenoma patients.
Prolifèrative activity of the colonic
epithelium is only one side of the car-
cinogenic process. [n the early devel-
opment of tumors the balance between
cell prolitèration and cell death is de-
ranged. When DNA is damaged by e.g.
chemical substances. cells enroll in a
genetically controlled programmed cell
death, apoptosis, which is started by
increased production of the p53 protein.
P53 in conjunction with p2lIWAF, an
inhibitor of cyclin-dependent kinases,
which are necessary tbr entry into the
S-phase of the cell cycle, stops cell di-
vision at the G1-S phase. At this point
either DNA is repaired and cell division
is resumed, or cells undergo p53-medi-
atecl apoptosis, a process which is fur-
ther regulated by members of the bcl-2
farnily. containing both inhibitors and
promoters of apoptosis. Failure of cells
to undergo apoptotic cell death despite
irreparable DNA-damage can lead tcr
uncontrolled proliferation of genetically
altered cells and ultimately thc Íbrrna-
tion of a neoplasm. Bci-2. an inhibitor
of p53 rnediated apoptosis. is indeed
tiequently abnormally activateci at an
early stage of colorectal carcinogenesis.
The second part of this thesis Íbcuses
on mechanisms involvccl in carcino-
genesis and the role of proliÍ 'eration,
apoptosis and mecliators t f the apop-
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to t ic  pathway.  us ing scnnosic lc  laxa-
tives as a nrodcl to str-rcly thc cfl 'ects o1'a
cytotox ic  ancl  possib lv  carc ino-scnic
substancc on colonic  cpi thc l iunr .
Sennoside larat ivcs are drugs o l  natura l
origin conrn'ronl1' uscd lbr short-ternr
treatrlrent ol ' constipation and Íirr cl iag-
nostic procedures that recluire bowel
c lcansing.  Short - tcrn. r  adnr in is t la t ion o l '
thcse laxat ives is  scnerra l ly  considcrecl
safc u'ithor.rt any acutc ol ' long-te nl
danger of  enhanccd colo lecta l  cancel '
r i s k .  Howeve r .  ch lon i c  usc  o l ' t hesc
laxat ives induccs pseuclonre lanosis col i .
a condition charactcrizc'cl by a blownislr
pignrentation ol' the colonic nrucosil.
and th is  has been associatcd wi th an
enhanced r isk o l '  co lorecta l  cancer .
Chapter 6 reviews sennosidc and other'
anth l 'anoid laxat ivcs and thei l  potent ia l
carc inogcnic e1l 'ects as ev idcnt  l l 'onr  in
r" i t ro .  aninra l  and hunran studies.
A s in{r lc  h igh c lose o l '  scnnosidc laxa-
t ivcs is  o l tcr r  usecl  e i thcr  as a s inglc
agcnt  or  togcther  wi th othcr  laxat ivcs to
ensure an optinral howcl preparation íirr
colonoscopics or othel diagnostic
p loccdures.  Chapter  7 i r rvest igates
wl ' rether  sennoside laxat ives have any
acldit ional valuc or.r bowcl lava-qe and
whether thef inclucc any aclverse cÍl 'ccts
on colonic  n-rucosal  h is to logy.  A tota l
o1 l7 l  pat ients were randornized lbr
bowel  preparat ion wi th e i ther  I  ml /kg
bodyweight  of  a senna-conta in ing (2
nrg/ru l )  s1 ' rup and 3-5 I  lavage solut ion
or  lavagc solut ion a lonc.  Sennosidc
laxatives clid not inrprove bowel prepa-
ration but ar"r incrcase o1' rnononuclear
inf i l trate was obscrvcd in the lanrina
proplia oÍ' the coklnic mucosa, which
could interl 'cre with diagnostic inter'-
prc:tation of colonic biopsies. Thcreli lr:c
S t  t  n tn  t  t  u ' t .  t  o t  t  t  l  t t . t  i o r t . t  t t r  t t l  
. f t t  t  t t  t  t '  l t c  t  . t  l ta  L  t  i  t  c  s
bowe I  prcparat ion wi thout  sennosidcs is
prcÍ'erablc.
To 
-eain ins ight  in to thc sLrggcstec l  can-
cel plonroting clfect cll chronic scnno-
s ide ingcst ion.  the eÍ1 'ect  o1 'a s ingle
l l i g l r  d r ) s r '  sc l t l t t t s i de :  ( ) t l  l t 1 ' r op to : i 5 .
crypt  length.  pro l i lc rat ive act iv i t ) , .  p-53
ancl  bc l -2 erpression was evr luatec l  in
chapter Í1. Biopsies wcre obtained from
-1 rcgions of thc colorcctunr i.e..
coccunr. tri-ursVersc colon. sigrnoid
colon ancl  rectuur .  lhrnr  l -5  pat ients l8
hours al'tcl '  sennoside achrinistration
ancl  l5  contro l  pat icnts.  Se nnosic le
laxat ives reduccd crypt  length and
increased pro l i l 'c rat ive act iv i ly .  Bcl - l
e 'xpression was incrcascd in both
gfoups. whcn cr),pts werc shortcr'
r . rnt l / t r r '  Pt ' t r l i l 'c r l t ive l le  t i \  i l \  \ \  i l \
inet 'eused.  No c l ' í 'cet  ( ) t )  l t l ) ( )pt ( ) \ i \  ( ) r
p-53 exprcssion coulc l  bc obselved.
Wc hypothesizecl that sennosicles rap-
id ly  inc lucc apoptosis  o1 '  co lonic  epi thc-
l ia l  ce l ls .  wl . r ich lcsr" r l ts  in  thc obsened
shortcl crypts. Probabll, i ls a conipen-
satory rnechanisllr t() restorc ccllularit l ' .
pro l i lèrat ive zrct iv i ty  is  subsequcnt ly
increascd ancl  apoptosis  inh ib i ted.  To
test  th is  hypothcsis .  another  s tuc ly ,  as
clescribe'd in chapter 9, was performed
in l5  subjccts recc iv ing sennosides and
l5 contro l  pat icnts.  This  t inrc.  s icmoid
biopsies werc obtainecl 6 hours atier
sennoside ingestion ancl evaluatecl l i lr
apoptosis .  p-5 i .  p2 l /WAF ancl  bc l - l
cxpression ancl  l i ) r  pro l i fèrat i le  lc t iv-
i ty .  Archival  nrater ia l  krnr  27 pat ients
with pscucl<lnrcl alr osi s col i. re'prescnting
long- terr .n sennoside use,  was col lected.
Histo logical ly '  a  c l is t inct ion was nradc
between nxrdcrate and scvere l irrnrs ol '
pser.rdornelanosis coli. This nratcrial
rvas also analyzcd lbi thc ali lrenren-
190
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tioned parameters. Six hours aÍter sen-
noside adminis t rat ion apoptosis  was
induced, resulting in shorter crypts. Ex-
pression of p53 and p2\IWAF was in-
creased as well. whereas no effect on
bcl-2 or proliÍ'erative activity was ob-
served. In biopsies of patients with a
severe form of pseudomelanosis coli
the degree of apoptosis, intensity of p53
staining and p2llWAF expression were
also enhanced. Again no alteration of
bcl-2 expression or proliferative activ-
ity could be demonstrated. Remarkably,
crypt length was increased in biopsies
of severe pseudomelanosis coli pa-
tients. From this study it can be con-
cluded that within 6 hours sennosides
induce apoptosis probably by a p53,
p2lAVAF mediated pathway, which
leads to crypt shortening. Despite a
higher degree of apoptosis in patients
with severe pseudomelanosis coli, an
increasing number of cells seems to
become refractory to apoptotic cell
death, causing crypt lengthening with-
out rise in proliferative activity or bcl-2
expression and thus possibly enhancing
the risk of colorectal cancer.
Chapter 10 investigates the in vitro
effects of different anthranoid laxatives.
including rhein, the active metabolite of
senna, aloe emodin and danthron. In-
duction of apoptosis, interaction with
DNA and cytotoxicity of these sub-
stances were evaluated using different
carcinoma cell lines. Interference with
anthranoid-induced cytotoxicity by
mechanisms involved in multidrug re-
sistance, such as the drug efflux pumps
Pgp and MRP1 and the topoisomerase
enzymes, were studied as well. Pgp and
MRPI drug efflux pumps are present in
normal colonic epithelium and probably
Chapter I I
protect colonic epithelial cells against
damage induced by xenobiotics by
pumping these substances out of the
cells. All anthranoid laxatives tested by
means of the MTT cytotoxicity assay
were cytotoxic to different carcinoma
cell lines. The MRPL drug efflux pump
was involved in protection against
rhein-induced cytotoxicity as rhein was
more toxic to the GLC4 cell-line than
to its MRPl-overexpressing subline
GLC4IADR. Pgp and topoisomerases
were not involved in reduction of rhein
cytotoxicity. Rhein did not intercalate
in DNA but induced apoptosis in all
cell lines tested. No resistance mecha-
nism was observed for aloe emodin and
danthron. From this study it can be
concluded that rhein induces apoptosis
and that the drug efflux pump MRP1
protects against rhein-induced cytotox-
icity in an in vitro setting.
Conclusions and future perspectives
ln this thesis colorectal cancer is ap-
proached from three different sides: re-
gional differences of luminal and
epithelial factors involved in colorectal
carcinogenesis, modulation of these
factors by means of chemical and die-
tary intervention and mechanisms of
the carcinogenic process itself.
Regional diJferences of luminal and
epithelial factors inv olved in c olorectal
carcinogenesis
In populations with a high risk of colo-
rectal cancer tumors predominantly
develop in the distal colon. This is gen-
erally ascribed to dietary factors and
composition of luminal colonic con-
1 9 1
